Malegra FXT Plus is a combination medication used to treat erectile dysfunction (ED) and premature ejaculation (PE) in men. It contains Sildenafil citrate, a phosphodiesterase type 5 (PDE5) inhibitor, and Dapoxetine, a selective serotonin reuptake inhibitor (SSRI). While effective for sexual performance, caution is needed when taking it with blood thinners (anticoagulants), such as warfarin, rivaroxaban, apixaban, or dabigatran.
Sildenafil can slightly increase the risk of bleeding in some individuals because it may influence platelet function and blood vessel dilation. Dapoxetine, as an SSRI, can also affect platelet activity, potentially enhancing the anticoagulant effect of blood thinners. When combined, these effects may increase the risk of bruising, nosebleeds, or prolonged bleeding.
Precautions: Men taking blood thinners should consult a healthcare professional before using Malegra FXT Plus. The doctor may adjust the dose, monitor INR levels (for warfarin users), or recommend additional monitoring for signs of bleeding. Avoid self-medicating or increasing the dose without supervision.
Other general precautions include avoiding nitrates, following prescribed doses, and watching for side effects such as dizziness, headache, or prolonged erections.
In summary, Malegra FXT Plus can interact with blood thinners, increasing bleeding risk, and should only be used under strict medical supervision.
Français
